N
Patient 1
THIS EVENT OCCURRED IN (B)(6). (B)(4).
| Seq | Brand | Generic | Manufacturer | Product code | Model | Catalog | Lot | PMA | 510(k) | Implant | Evaluated | Availability |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 | COBAS 8000 E602 MODULE | IMMUNOCHEMISTRY ANALYZER | ROCHE DIAGNOSTICS | JMG | NA | 05990378001 | NA | R | Y | |||
| 1 | COBAS 8000 E602 MODULE | IMMUNOCHEMISTRY ANALYZER | ROCHE DIAGNOSTICS | JJE | NA | 05990378001 | NA | R | Y |
| Sequence | Received | Treatment | Outcome |
|---|---|---|---|
| 1 | 2016-03-28 | 0 |
Patient 1
THIS EVENT OCCURRED IN (B)(6). (B)(4).
Patient 1
THE CUSTOMER STATED THAT THEY RECEIVED AN ERRONEOUS RESULT FOR ONE PATIENT SAMPLE TESTED FOR FERRITIN ON AN E602 ANALYZER. THE SAMPLE INITIALLY RESULTED AS 1.19 UG/L AND THIS VALUE WAS REPORTED OUTSIDE OF THE LABORATORY TO THE PHYSICIAN. THE PHYSICIAN DID NOT TRUST THE RESULT AND ASKED FOR THE SAMPLE TO BE REPEATED. THE SAMPLE WAS REPEATED ON THE SAME ANALYZER, RESULTING AS 20.17 UG/L. THE SAMPLE WAS ALSO REPEATED ON AN E170 ANALYZER, RESULTING AS 18.46 UG/L. THE REPEAT RESULT WAS BELIEVED TO BE CORRECT. THE PATIENT WAS NOT ADVERSELY AFFECTED. THE FERRITIN REAGENT LOT NUMBER WAS 121669. THE REAGENT EXPIRATION DATE WAS ASKED FOR, BUT NOT PROVIDED. THE FIELD SERVICE ENGINEER FOUND THAT REAGENT CUPS ON THE ANALYZER WERE DIRTY. HE CLEANED THE CUPS AND PERFORMED A MEASURING CELL PREPARATION. HE CHECKED SAMPLE ADJUSTMENT AND THIS WAS OK. HE DID NOT DETECT ANY OTHER ISSUES WITH THE SYSTEM. HE RAN PERFORMANCE TESTING. HE STATED THAT THE OVERALL CLEANLINESS OF THE LABORATORY WAS GOOD.
Patient 1
IT WAS STATED THAT THE PERFORMANCE TESTING RUN ON THE ANALYZER WAS SUCCESSFUL. A SPECIFIC ROOT CAUSE COULD NOT BE DETERMINED BASED ON THE PROVIDED INFORMATION. A GENERAL REAGENT OR INSTRUMENT ISSUE COULD NOT BE SEEN.